Anesthetic induction with fentanyl and intravenous lidocaine for coronary artery surgery.
In a randomized, double-blind trial, 59 patients undergoing coronary artery surgery received fentanyl 10, 15, or 25 microg/kg infused over 5 minutes for anesthetic induction. Half of the patients received intravenous lidocaine, 1.5 mg/kg, 1 minute before laryngoscopy. Efficacy of induction as judged by loss of consciousness was evaluated, and hemodynamic values during induction, laryngoscopy, and tracheal intubation were recorded each minute for 10 minutes. Plasma fentanyl concentrations were determined after termination of the fentanyl infusion. Opioid induction with fentanyl was successful in 90% (18 of 20) of patients receiving 25 microg/kg, 89% (17 of 19) of patients receiving 15 microg/kg, but only 55% (11 of 20) of patients receiving 10 microg/kg (P < .01). While plasma fentanyl concentrations were proportional to the dose infused (25 ng/mL, 18 ng/mL, and 14 ng/mL in the 25, 15. and 10 microg/kg fentanyl groups, respectively), there was no relationship between plasma fentanyl concentration and hemodynamic response to laryngoscopy or intubation. Opioid induction caused a gradual decrease in blood pressure that was restored with intubation. Lidocaine partially blocked this restoration (systolic blood pressure 122 +/- 5 v 138 +/- 5 mmHg, lidocaine v placebo, 1 minute after laryngoscopy, P < .05). Fentanyl, 15 or 25 microg/kg, intravenously, is an effective induction agent for patients with coronary artery disease. Supplementation with intravenous lidocaine, 1.5 mg/kg, will obtund the increase in blood pressure that occurs with laryngoscopy and intubation and help prevent infrequent hypertensive responses seen with this opioid technique.
Mark
J B
JB
Department of Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston 02115, USA.
Horrow
J C
JC
Eckenbrecht
P D
PD
Smalky
M
M
Arthur
G R
GR
Dhingra
U
U
Murray
E
E
D000759:Adjuvants, Anesthesia / Q000494:pharmacology*; D000368:Aged; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000704:Analysis of Variance; D000768:Anesthesia, General; D000771:Anesthesia, Intravenous; D019162:Anesthetics, Combined; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D001026:Coronary Artery Bypass; D004311:Double-Blind Method; D005260:Female; D005283:Fentanyl / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007828:Laryngoscopy / Q000009:adverse effects; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged
D000759:Adjuvants, Anesthesia; D000701:Analgesics, Opioid; D019162:Anesthetics, Combined; D000889:Anti-Arrhythmia Agents; D008012:Lidocaine; D005283:Fentanyl